HLB Pharmaceutical CEO Park Jae Hyung raises stake to 1.51% via paid-in capital increase at KRW 5,650/share
Bitget2026/09/28 04:18- HLB Pharmaceutical CEO Park Jae Hyung’s stake held steady at 657,378 shares, or 1.51%, as of Sept. 21, 2026.
- Common shares rose by 92,652 to 657,378 through a paid-in rights offering priced at KRW 5,650 per share.
- Warrants for 92,652 shares expired following the capital increase, leaving total voting shares unchanged.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
2026 September US stock model trading review: 18 complete transaction details
Confidence among major Japanese manufacturers hits an eight-year high, fueling expectations for Bank of Japan interest rate hikes.
According to the quarterly Tankan survey released by the Bank of Japan on Thursday, the business sentiment index for large manufacturers rose from 22 to 24 in September, marking the sixth consecutive quarter of improvement and reaching the highest level in more than eight years.
$6.2 million, a whale withdrew 39,018 AAVE from an exchange
Synopsys (SNPS.US) partners with OpenAI to develop AI models for chip design, revenue-sharing model drives stock price up by 7%
On Wednesday, chip design software provider Synopsys (SNPS.US) announced that it has reached a partnership agreement with OpenAI. Both parties will jointly develop AI models for the chip business and share related revenues.
Crypto prices
More
